Author Question: Which of the following questions is most relevant for evaluating whether Nanocell should partner ... (Read 33 times)

kellyjaisingh

  • Hero Member
  • *****
  • Posts: 540
Which of the following questions is most relevant for evaluating whether Nanocell should partner with an agent or foreign distributor to expand its overseas sales?
 
  A) Has FDI been successfully used by solar technology companies expanding abroad?
  B) What would be the cost of capital required to finance additional expansion?
  C) Who do Nanocell's competitors typically collaborate with when expanding operations?
  D) Does Nanocell have an appropriate legal team in place to handle the requirements of expansion?

Question 2

In a short essay, describe the three key types of focal firms, and explain how their value chain enables international business.
 
  What will be an ideal response?



briseldagonzales

  • Sr. Member
  • ****
  • Posts: 303
Answer to Question 1

C

Answer to Question 2

Great help.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

For a complete list of videos, visit our video library